Bank of America’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $73.5M | Sell |
2,041,344
-1,984,239
| -49% | -$71.5M | 0.01% | 1220 |
|
|
2025
Q1 | $125M | Buy |
4,025,583
+1,039,998
| +35% | +$32.4M | 0.01% | 864 |
|
|
2024
Q4 | $76.2M | Buy |
2,985,585
+950,880
| +47% | +$24.3M | 0.01% | 1069 |
|
|
2024
Q3 | $57.6M | Buy |
2,034,705
+16,110
| +0.8% | +$456K | ﹤0.01% | 1268 |
|
|
2024
Q2 | $53.2M | Buy |
2,018,595
+115,353
| +6% | +$3.04M | ﹤0.01% | 1260 |
|
|
2024
Q1 | $57.8M | Buy |
1,903,242
+559,256
| +42% | +$17M | 0.01% | 1223 |
|
|
2023
Q4 | $37.8M | Sell |
1,343,986
-151,288
| -10% | -$4.25M | ﹤0.01% | 1343 |
|
|
2023
Q3 | $40.6M | Sell |
1,495,274
-51,257
| -3% | -$1.39M | ﹤0.01% | 1226 |
|
|
2023
Q2 | $47.5M | Sell |
1,546,531
-335,879
| -18% | -$10.3M | 0.01% | 1186 |
|
|
2023
Q1 | $67.8M | Buy |
1,882,410
+558,884
| +42% | +$20.1M | 0.01% | 1039 |
|
|
2022
Q4 | $52.3M | Sell |
1,323,526
-176,020
| -12% | -$6.96M | 0.01% | 1112 |
|
|
2022
Q3 | $60.3M | Sell |
1,499,546
-139,381
| -9% | -$5.6M | 0.01% | 1009 |
|
|
2022
Q2 | $68.9M | Sell |
1,638,927
-321,601
| -16% | -$13.5M | 0.01% | 974 |
|
|
2022
Q1 | $76.4M | Buy |
1,960,528
+89,239
| +5% | +$3.48M | 0.01% | 1002 |
|
|
2021
Q4 | $74.6M | Sell |
1,871,289
-18,362
| -1% | -$732K | 0.01% | 1008 |
|
|
2021
Q3 | $68.3M | Buy |
1,889,651
+297,095
| +19% | +$10.7M | 0.01% | 1054 |
|
|
2021
Q2 | $65.3M | Buy |
1,592,556
+166,677
| +12% | +$6.83M | 0.01% | 1088 |
|
|
2021
Q1 | $62.2M | Buy |
1,425,879
+983,540
| +222% | +$42.9M | 0.01% | 1056 |
|
|
2020
Q4 | $22.1M | Buy |
442,339
+283,341
| +178% | +$14.2M | ﹤0.01% | 1553 |
|
|
2020
Q3 | $6.69M | Buy |
158,998
+155,967
| +5,146% | +$6.56M | ﹤0.01% | 2328 |
|
|
2020
Q2 | $147K | Buy |
+3,031
| New | +$147K | ﹤0.01% | 4902 |
|